Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Luca Pierantoni

Biographic Data

ID7603800
NAMELuca Pierantoni
GIVEN NAMESLuca
FAMILY NAMEPierantoni
SIGNATUREPIERANTONI L
AFFILIATIONSAzienda USL di Bologna
ORCID0000-0001-8175-5488
VERIFIEDYes
TOTAL WORKS6
TOTAL CITATIONS0
WORKS AS AUTHOR6
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2020
LATEST PUBLICATION YEAR2022
H-INDEX0
  • Clinical Outcome of Discordant Empirical Therapy and Risk Factors Associated to Treatment Failure in Children Hospitalized for Urinary Tract Infections

    Open Access•Giovanni Autore, Cosimo Neglia et al.•ARTICLE•Children•2022

    With the spread of antibiotic resistance in pediatric urinary tract infections (UTIs), more patients are likely to be started empirically on antibiotics to which pathogens are later found to be resistant (discordant therapy). However, in-vivo effectiveness may be different from in-vitro susceptibility. Aims of this study were to describe clinical outcomes of discordant empirical treatments in pediatric UTIs and to investigate risk factors associa…

  • Comparison between Short Therapy and Standard Therapy in Pediatric Patients Hospitalized with Urinary Tract Infection

    Open Access•Danilo Buonsenso, Giorgio Sodero et al.•ARTICLE•Children•2022

    Introduction: There is marked heterogeneity in clinicians’ choice of antibiotic duration for pediatric urinary tract infections (UTIs). Most patients with bacterial UTIs still receive between 7 and 10 days of antibiotics. Prolonged antibiotic exposure drives the emergence of resistance and increases the occurrence of adverse effects. There is increasing evidence that shorter antibiotic regimens may be equally effective compared with longer ones. …

  • Epidemiology, Microbiology and Severity of Bronchiolitis in the First Post-Lockdown Cold Season in Three Different Geographical Areas in Italy

    Open Access•Anna Camporesi, Rosa Morello et al.•ARTICLE•Children•2022

    The aim of this study was to understand the epidemiology, disease severity, and microbiology of bronchiolitis in Italy during the 2021-2022 cold season, outside of lockdowns. Before COVID-19, the usual bronchiolitis season in Italy would begin in November and end in April, peaking in February. We performed a prospective observational study in four referral pediatric centers located in different geographical areas in Italy (two in the north, one i…

  • Three-Year Trend in Escherichia coli Antimicrobial Resistance among Children’s Urine Cultures in an Italian Metropolitan Area

    Open Access•Luca Pierantoni, Laura Andreozzi et al.•ARTICLE•Children•2021

    Urinary tract infections (UTIs) are among the most common bacterial infections in children, and Escherichia coli is the main pathogen responsible. Several guidelines, including the recently updated Italian guidelines, recommend amoxicillin-clavulanic acid (AMC) as a first-line antibiotic therapy in children with febrile UTIs. Given the current increasing rates of antibiotic resistance worldwide, this study aimed to investigate the three-year tren…

  • Impact of Sars-CoV-2 Pandemic on Bronchiolitis Hospitalizations

    Open Access•Giacomo Stera, Luca Pierantoni et al.•ARTICLE•Children•2021

    SARS-CoV-2 pandemic restrictions have deeply altered the common respiratory illnesses burden. The aim of this paper was to clarify how these measures may have influenced bronchiolitis epidemiology, exploring possible explanations. We studied 342 infants hospitalized for bronchiolitis at our center from four different epidemic seasons (October-April 2017-2018, 2018-2019, 2019-2020 and 2020-2021). March-April hospitalization rate, RSV (respiratory …

  • Covid-19 in children and adolescents in Europe

    Open Access•Florian Götzinger, Begoña Santiago-García et al.•ARTICLE•The Lancet Child & Adolescent…•2020

No prominent works on this page.

  • Covid-19 in children and adolescents in Europe

    Open Access•Florian Götzinger, Begoña Santiago-García et al.•ARTICLE•The Lancet Child & Adolescent…•2020

  • Three-Year Trend in Escherichia coli Antimicrobial Resistance among Children’s Urine Cultures in an Italian Metropolitan Area

    Open Access•Luca Pierantoni, Laura Andreozzi et al.•ARTICLE•Children•2021

    Urinary tract infections (UTIs) are among the most common bacterial infections in children, and Escherichia coli is the main pathogen responsible. Several guidelines, including the recently updated Italian guidelines, recommend amoxicillin-clavulanic acid (AMC) as a first-line antibiotic therapy in children with febrile UTIs. Given the current increasing rates of antibiotic resistance worldwide, this study aimed to investigate the three-year tren…

  • Impact of Sars-CoV-2 Pandemic on Bronchiolitis Hospitalizations

    Open Access•Giacomo Stera, Luca Pierantoni et al.•ARTICLE•Children•2021

    SARS-CoV-2 pandemic restrictions have deeply altered the common respiratory illnesses burden. The aim of this paper was to clarify how these measures may have influenced bronchiolitis epidemiology, exploring possible explanations. We studied 342 infants hospitalized for bronchiolitis at our center from four different epidemic seasons (October-April 2017-2018, 2018-2019, 2019-2020 and 2020-2021). March-April hospitalization rate, RSV (respiratory …

  • Clinical Outcome of Discordant Empirical Therapy and Risk Factors Associated to Treatment Failure in Children Hospitalized for Urinary Tract Infections

    Open Access•Giovanni Autore, Cosimo Neglia et al.•ARTICLE•Children•2022

    With the spread of antibiotic resistance in pediatric urinary tract infections (UTIs), more patients are likely to be started empirically on antibiotics to which pathogens are later found to be resistant (discordant therapy). However, in-vivo effectiveness may be different from in-vitro susceptibility. Aims of this study were to describe clinical outcomes of discordant empirical treatments in pediatric UTIs and to investigate risk factors associa…

  • Comparison between Short Therapy and Standard Therapy in Pediatric Patients Hospitalized with Urinary Tract Infection

    Open Access•Danilo Buonsenso, Giorgio Sodero et al.•ARTICLE•Children•2022

    Introduction: There is marked heterogeneity in clinicians’ choice of antibiotic duration for pediatric urinary tract infections (UTIs). Most patients with bacterial UTIs still receive between 7 and 10 days of antibiotics. Prolonged antibiotic exposure drives the emergence of resistance and increases the occurrence of adverse effects. There is increasing evidence that shorter antibiotic regimens may be equally effective compared with longer ones. …

  • Epidemiology, Microbiology and Severity of Bronchiolitis in the First Post-Lockdown Cold Season in Three Different Geographical Areas in Italy

    Open Access•Anna Camporesi, Rosa Morello et al.•ARTICLE•Children•2022

    The aim of this study was to understand the epidemiology, disease severity, and microbiology of bronchiolitis in Italy during the 2021-2022 cold season, outside of lockdowns. Before COVID-19, the usual bronchiolitis season in Italy would begin in November and end in April, peaking in February. We performed a prospective observational study in four referral pediatric centers located in different geographical areas in Italy (two in the north, one i…

Medicine (6 works) · Internal Medicine (5 works) · Pediatrics (5 works) · Antibiotics (3 works) · Pediatric Urology and Nephrology Studies (3 works) · Respiratory viral infections research (3 works) · Urinary Tract Infections Management (3 works) · Biology (2 works) · Bronchiolitis (2 works) · Disease (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae